Efficacy and Safety of Vildagliptin in Combination With Pioglitazone in Patients With Type 2 Diabetes.
Phase of Trial: Phase III
Latest Information Update: 01 Mar 2017
At a glance
- Drugs Pioglitazone (Primary) ; Vildagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Registrational; Therapeutic Use
- Sponsors Novartis
- 31 Aug 2018 Biomarkers information updated
- 01 Oct 2005 Primary endpoint 'Proportion-of-glycosylated-haemoglobin' has been met, according to results published in Diabetes, Obesity and Metabolism.
- 01 Oct 2005 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History